Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Aug;28(8):1734-8.
doi: 10.1128/jcm.28.8.1734-1738.1990.

Use of acute-stage-specific antigens of Toxoplasma gondii for serodiagnosis of acute toxoplasmosis

Affiliations

Use of acute-stage-specific antigens of Toxoplasma gondii for serodiagnosis of acute toxoplasmosis

Y Suzuki et al. J Clin Microbiol. 1990 Aug.

Abstract

Antisera to acetone-fixed tachyzoites were prepared by immunizing rabbits intravenously with the fixed organisms. Immunoblots in which purified immunoglobulin G (IgG) of the antisera was used recognized four antigens of a supernatant (after centrifugation at 10,000 x g for 30 min) fraction of sonicated tachyzoites. A purified toxoplasma antigen fraction, referred to as acute-stage-specific (AC) antigen, that contained mainly three antigens was obtained by affinity chromatography by using the purified IgG. One antigen had a molecular weight of approximately 52,000, and two antigens had molecular weights of approximately 6,000. An enzyme-linked immunosorbent assay (AC-ELISA) in which this purified antigen fraction, obtained by affinity chromatography, was used for detection of IgG antibody detected early acute infection in sera of patients with toxoplasmic lymphadenopathy. Ninety-two percent of sera obtained within 2 months after onset of lymphadenopathy were positive in the AC-ELISA, whereas only 9% of sera obtained later than 5 months after onset of the clinical illness were positive. The AC-ELISA appears highly sensitive and specific for diagnosis of acute toxoplasmosis.

PubMed Disclaimer

References

    1. J Immunol. 1983 Aug;131(2):977-83 - PubMed
    1. Pathol Biol (Paris). 1986 Mar;34(3):173-7 - PubMed
    1. J Infect Dis. 1980 Aug;142(2):256-64 - PubMed
    1. J Exp Med. 1980 Feb 1;151(2):328-46 - PubMed
    1. N Engl J Med. 1978 Mar 9;298(10):550-3 - PubMed

Publication types